|

Peter Paul De Deyn, MD, PhD, MMPR
(Belgium), Board of Directors
Dr. De Deyn is the Scientific Director of
the Institute Born-Bunge at the University
of Antwerp. He completed his medical
training in neurology in Belgium and
specializes in the fields of clinical
neurology, neurochemistry and
neuropharmacology. In 1989, he became Head
of the Department of Neurochemistry and
Behavior at the University of Antwerp
followed by appointments in 1990, as Head of
the Department of Neurology at the Academic
Hospital in Middelheim, Belgium; in 1995, a
professorship in Animal Laboratory Sciences
and Behavioural Physiology followed by a
professorship in Neurology and Behavioral
Neurosciences. Since 1 October 2005, he has
been in his current position.
Dr. De Deyn has published more than 400
peer-reviewed papers on a variety of
clinical and research issues in dementia,
stroke, epilepsy, and metabolism, and has
edited a series of academic volumes in these
fields. During recent years, his main focus
of research has been on neurodegenerative
disorders including dementia and Parkinson’s
disease, both on a pre-clinical (animal
modeling) and clinical level. He is author
of several monographs. His research
interests also include functional
neuroimaging and ethical issues related to
the field of clinical neurosciences. He is a
member of several international scientific
societies and has editorial responsibilities
for several peer-reviewed journals. He is
Editor-in-Chief of Clinical Neurology and
Neurosurgery. In addition, he is Founder and
Chairman of the Prize Frans Dille for
promotion of graphic arts held in
collaboration with the Plantin-Moretus
Museum in Antwerp (cultural site included on
the UNESCO’s World Heritage List).
Dr. De Deyn has been on the Board of
Directors since 2009. He can be contacted at
dedeyn@skynet.be.
Return to previous page.
|